Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis

There is highly credible evidence that melatonin mitigates cancer at the initiation, progression and metastasis phases. In many cases, the molecular mechanisms underpinning these inhibitory actions have been proposed. What is rather perplexing, however, is the large number of processes by which mela...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiter, Russel J., Rosales-Corral, Sergio A., Tan, Dun-Xian, Acuna-Castroviejo, Dario, Qin, Lilan, Yang, Shun-Fa, Xu, Kexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412427/
https://www.ncbi.nlm.nih.gov/pubmed/28420185
http://dx.doi.org/10.3390/ijms18040843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412427/
https://www.ncbi.nlm.nih.gov/pubmed/28420185
http://dx.doi.org/10.3390/ijms18040843

Ejemplares similares